Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Emma Nichols und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Biomarkers, Dementia, Cognition, Social Class. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institutes of Health/National Institute on Aging.
Abstract (Originalsprache)
INTRODUCTION Socioeconomic factors influence cognitive outcomes and may modify associations between neuropathologies and cognitive outcomes, yet evidence from low‐ and middle‐income contexts remains scarce. METHODS We used harmonized data from nationally representative studies in the United States (Health and Retirement Study ‐ Harmonized Cognitive Assessment Protocol [HRS‐HCAP]; N = 1956) and India (Longitudinal Aging Study in India ‐ Diagnostic Assessment of Dementia [LASI‐DAD]; N = 1485) and multivariable‐adjusted linear regression models to examine effect modification of associations between blood biomarkers of neuropathology (amyloid beta [Aβ]42/40, phosphorylated tau [p‐tau‐181], glial fibrillary acidic protein [GFAP], and neurofilament light chain [NfL]) and dementia‐related outcomes (cognitive functioning, dementia) by socioeconomic factors (educational attainment, paternal education, and total household wealth and assets). RESULTS Neuropathology biomarkers were associated with cognitive outcomes in both samples; however, no consistent evidence of effect modification by socioeconomic factors was observed across included biomarkers or cognitive measures. DISCUSSION These findings suggested limited modification of blood biomarker–cognition relationships by socioeconomic status in diverse settings, potentially influenced by random measurement error, regression dilution bias, and low power. Further comparisons across biomarker modalities are warranted to clarify expected associations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Economic and Social Research, University of Southern California, Los Angeles, California, USA.
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
- Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Division of Geriatric Medicine, University of California, Los Angeles, Los Angeles, California, USA.
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Emma Nichols
Förderung
- NIA NIH HHS
- National Institutes of Health/National Institute on Aging
Zitieren
APA
Nichols, E., Kim, J. K., Aksman, L. M., Gross, A. L., Hu, P., Kobayashi, L. C., Thyagarajan, B., Lee, J., & Crimmins, E. M. (2026). Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71729
Vancouver
Nichols E, Kim JK, Aksman LM, Gross AL, Hu P, Kobayashi LC, et al. Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71729
BibTeX
@article{Nichols2026,
author = {Nichols, Emma and Kim, Jung Ki and Aksman, Leon M and Gross, Alden L and Hu, Peifeng and Kobayashi, Lindsay C and Thyagarajan, Bharat and Lee, Jinkook and Crimmins, Eileen M},
title = {Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71729}
}
EUVIMED